Pathology testing can determine if a tumor is er+. Unless otherwise contraindicated, all er+ patients should be considered for hormone therapy
. If strongly er+, they may get more benefit from this than from chemotherapy
. Specialized testing (oncotype dx) is often used to determine if chemotherapy is still needed in er+ pt.